Personal information

Emails & domains

Verified email domains

Other IDs

SciProfiles: 2500113

Activities

Collapse all

Employment (3)

Universidade da Coruña: A Coruña, A Coruña, ES

2022-12-16 to present | Tecnico de Apoyo a la investigación (Facultad de Informatica)
Employment
Source: Self-asserted source
Andrea Cuartero Martí­nez

Fundacion Universidade da Coruña: A Coruna, Galicia, ES

2022-09-16 to 2022-12-15 | Ayudante de investigación (Centro de Investigacion en Tecnologias de la Informacion y las Comunicaciones)
Employment
Source: Self-asserted source
Andrea Cuartero Martí­nez

Fundación Instituto de Investigación Sanitaria de Santiago de Compostela: Santiago de Compostela, Galicia, ES

2021-08-01 to 2022-09-15 | Investigadora graduada
Employment
Source: Self-asserted source
Andrea Cuartero Martí­nez

Education and qualifications (2)

Universidade de Santiago de Compostela: Santiago de Compostela, La Coruña, ES

2020 to 2021 | MASTER UNIVERSITARIO EN OPTOMETRÍA (Facultad de Optica y Optometría)
Education
Source: Self-asserted source
Andrea Cuartero Martí­nez

Universidad de Zaragoza Facultad de Ciencias: Zaragoza, Aragón, ES

2015 to 2020 | Grado en Optica y Optometría (Facultad de Ciencias)
Education
Source: Self-asserted source
Andrea Cuartero Martí­nez

Works (5)

Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study

International Journal of Molecular Sciences
2024-09 | Journal article | Author
DOI: 10.3390/ijms25189847
Contributors: María Puente Iglesias; Andrea Cuartero Martí­nez; ROSARIO TOURIÑO-PERALBA; María Teresa Rodríguez-Ares; Maria J Giraldez; Eva Yebra-Pimentel; Laura García-Quintanilla; Xurxo García-Otero; Miguel González-Barcia; Irene Zarra-Ferro et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics

International Journal of Pharmaceutics
2024-09 | Journal article
DOI: 10.1016/j.ijpharm.2024.124516
Contributors: Andrea Cuartero-Martínez; Xurxo García-Otero; Jessica Codesido; Noemí Gómez-Lado; Jesús Mateos; Susana B. Bravo; Carmen Antía Rodríguez-Fernández; Miguel González-Barcia; Pablo Aguiar; Marcos Ortega-Hortas et al.
Source: check_circle
Crossref

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence

Pharmaceutics
2023-11 | Journal article | Author
DOI: 10.3390/pharmaceutics15112589
Contributors: Ana Castro Balado; Andrea Cuartero Martí­nez; Hugo Pena-Verdeal; Gonzalo Hermelo-Vidal; Anja Schmidt; Belén Montero; Manuela Hernández-Blanco; Irene Zarra-Ferro; Miguel González-Barcia; Cristina Mondelo-García et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Stability of insulin eye drops in the treatment of refractory corneal ulcers.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
2022-11-25 | Journal article
PMID: 36520572
Contributors: Cuartero-Martínez A; Hermelo-Vidal G; Castro-Balado A; Gómez-García Á; González-Barcia M; Otero-Espinar FJ; Fernández-Ferreiro A; Mondelo-García C
Source: Self-asserted source
Andrea Cuartero Martí­nez

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence.

Pharmaceutics
2022-10-15 | Journal article
DOI: 10.3390/pharmaceutics14102194
PMID: 36297629
PMC: PMC9607622
Contributors: Ana Castro Balado; Enrique José Bandín Vilar; Cuartero-Martínez A; García-Quintanilla L; Hermelo-Vidal G; Xurxo García-Otero; Rodríguez-Martínez L; Jesús Mateos; Hernández-Blanco M; Pablo Aguiar et al.
Source: Self-asserted source
Andrea Cuartero Martí­nez
grade
Preferred source (of 3)‎
How many people are using ORCID?